NCT02488057View on ClinicalTrials.gov

Improving Beta Cell Function in Mexican American Women With Prediabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Pre-Diabetes
Interventions
DRUG

Liraglutide

Active comparator. See arm descriptions.

BEHAVIORAL

Weight loss

Active comparator. See arm descriptions.

Trial Locations (4)

77011

Magnolia Multiservice Center, Houston

77020

Denver Harbor Multi-service Center, Houston

90048

Cedars-Sinai Medical Center, Los Angeles

90502

L.A. Biomedical Research Institute, Torrance

All Listed Sponsors
lead

Ohio State University

OTHER

NCT02488057 - Improving Beta Cell Function in Mexican American Women With Prediabetes | Biotech Hunter | Biotech Hunter